No profile data available.
TransMedics Group, Inc. (TMDX) is a healthcare company in the protection and sanitization healthcare products industry, based in Andover, United States, with about 898 full-time employees.
It reported revenue of $605.49 million for fiscal year 2025, up 37.1% from fiscal year 2024, and net income of $190.29 million. United States was its largest region in fiscal year 2025, with 97% of revenue. Its market capitalization was $2.69 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
TransMedics reported $605.49 million in revenue for fiscal year 2025, up 37.1% from $441.54 million in fiscal year 2024.
United States: 97% of revenue by region in fiscal year 2025, followed by ALL Other Countries (3%).
$2.69 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (protection and sanitization healthcare products) include Ansell Limited (ANSLY), Figs, Inc. (FIGS).